EXPEDITED PUBLICATION
Stress Cardiomyopathy After Intravenous Administration of Catecholamines and Beta-Receptor Agonists
Jacob Abraham, MD*,
James O. Mudd, MD*,
Navin Kapur, MD ,
Kelly Klein*,
Hunter C. Champion, MD, PhD* and
Ilan S. Wittstein, MD*,*
* Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
Division of Cardiology, Tufts Medical Center, Boston, Massachusetts
Manuscript received December 8, 2008;
revised manuscript received February 19, 2009,
accepted February 24, 2009.
* Reprint requests and correspondence: Dr. Ilan S. Wittstein, Division of Cardiology, Johns Hopkins Hospital, Carnegie 568, 600 North Wolfe Street, Baltimore, Maryland 21287 (Email: iwittste{at}jhmi.edu).
Objectives: The aim of this study was to report a series of patients with stress cardiomyopathy precipitated by the intravenous administration of catecholamines and beta-receptor agonists.
Background: Stress cardiomyopathy is a syndrome of transient cardiac dysfunction precipitated by intense emotional or physical stress. Excessive sympathetic stimulation is believed to be central to the pathogenesis of this disorder, but a causal link has not been convincingly demonstrated.
Methods: We observed 9 cases of stress cardiomyopathy precipitated immediately by the intravenous administration of epinephrine (n = 6) or dobutamine (n = 3). Patients were evaluated with coronary angiography and with serial echocardiography, electrocardiography, and cardiac enzymes.
Results: The median age was 44 years (interquartile range [IQR]: 30 to 48 years), and 7 (78%) were woman. Troponin-I was mildly elevated (median 4.07 ng/ml, IQR: 0.47 to 5.63 ng/ml), but none of the patients undergoing angiography had obstructive coronary disease. All patients developed corrected QT interval (QTc interval) prolongation (median QTc interval 504 ms, IQR: 477 to 568 ms) within 24 h of receiving drug. All 3 previously described variants of left ventricular "ballooning" (apical, midventricular, and basal) were observed. The median ejection fraction on admission was 35% (IQR: 35% to 40%). During follow-up (median 7 days, IQR: 4 to 13 days) there was recovery of left ventricular systolic function in all patients (median ejection fraction 55%, IQR: 40% to 60%, p < 0.001 vs. admission).
Conclusions: Exposure to catecholamines and beta-receptor agonists used routinely during procedures and diagnostic tests can precipitate all the features of stress cardiomyopathy, including cardiac isoenzyme elevation, QTc interval prolongation, and rapidly reversible cardiac dysfunction. These observations strongly implicate excessive sympathetic stimulation as central to the pathogenesis of this unique syndrome.
Key Words: beta-receptor agonists catecholamines stress cardiomyopathy ventricular ballooning
|
Abbreviations and Acronyms
| | ECG = electrocardiogram/electrocardiographic | | IABP = intra-aortic balloon pump | | IQR = interquartile range | | LV = left ventricle/ventricular | | QTc interval = corrected QT interval | | SCM = stress cardiomyopathy |
|
This article has been cited by other articles:

|
 |

|
 |
 
M. Glamore, C. Wolf, J. Boolbol, and M. Kelly
Broken Heart Syndrome: A Risk of Teenage Rhinoplasty
Aesthetic Surgery Journal,
January 1, 2012;
32(1):
58 - 60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-L. Looi, R. Gabriel, A. Khan, A. To, M. Lee, R. Stewart, and A. J. Kerr
Left ventricular morphology and response to beta-adrenergic stimulation in apical ballooning syndrome
Eur Heart J Cardiovasc Imaging,
December 30, 2011;
(2011)
jer303v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Eitel, F. von Knobelsdorff-Brenkenhoff, P. Bernhardt, I. Carbone, K. Muellerleile, A. Aldrovandi, M. Francone, S. Desch, M. Gutberlet, O. Strohm, et al.
Clinical Characteristics and Cardiovascular Magnetic Resonance Findings in Stress (Takotsubo) Cardiomyopathy
JAMA,
July 20, 2011;
306(3):
277 - 286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Jhawar, S. Balla, M. A. Alpert, and A. Chockalingam
Left ventricular outflow tract and mid-cavity obstruction may cause false-positive dobutamine stress echocardiograms
Eur Heart J Cardiovasc Imaging,
March 1, 2011;
12(3):
E14 - E14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zeb, N. Sambu, P. Scott, and N. Curzen
Takotsubo cardiomyopathy: a diagnostic challenge
Postgrad. Med. J.,
January 1, 2011;
87(1023):
51 - 59.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. T. Hurst, A. Prasad, J. W. Askew III, P. P. Sengupta, and A. J. Tajik
Takotsubo Cardiomyopathy: A Unique Cardiomyopathy With Variable Ventricular Morphology
J. Am. Coll. Cardiol. Img.,
June 1, 2010;
3(6):
641 - 649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Hessel II and M. J. London
Takotsubo (Stress) Cardiomyopathy and the Anesthesiologist: Enough Case Reports. Let's Try to Answer Some Specific Questions!
Anesth. Analg.,
March 1, 2010;
110(3):
674 - 679.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Nykamp and J. A. Titak
Takotsubo Cardiomyopathy, or Broken-Heart Syndrome
Ann. Pharmacother.,
March 1, 2010;
44(3):
590 - 593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mansencal, R. El Mahmoud, and O. Dubourg
Occurrence of Tako-Tsubo Cardiomyopathy and Chronobiological Variation
J. Am. Coll. Cardiol.,
February 2, 2010;
55(5):
500 - 501.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Citro, M. Previtali, E. Bossone, and R. Manfredini
Reply.
J. Am. Coll. Cardiol.,
February 2, 2010;
55(5):
501 - 502.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. Sharkey, D. C. Windenburg, J. R. Lesser, M. S. Maron, R. G. Hauser, J. N. Lesser, T. S. Haas, J. S. Hodges, and B. J. Maron
Natural History and Expansive Clinical Profile of Stress (Tako-Tsubo) Cardiomyopathy
J. Am. Coll. Cardiol.,
January 26, 2010;
55(4):
333 - 341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, G. K. Feld, B. H. Greenberg, J. Hall, M. Hlatky, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, et al.
Highlights of the Year in JACC 2009
J. Am. Coll. Cardiol.,
January 26, 2010;
55(4):
380 - 407.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Omerovic
Did Jesus die of a 'broken heart'?
Eur J Heart Fail,
August 1, 2009;
11(8):
729 - 731.
[Full Text]
[PDF]
|
 |
|
|